Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial

NCT02541942 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT02541942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02541942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Completed
Start date
April 3, 2015
Completion date
April 15, 2016
Enrollment
19 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a with inhibitors, haemophilia b with inhibitors